Evaluate the Safety and Effectiveness of the AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery

Part of paid clinical trials in Cleveland, Ohio.

Sponsor
OnPoint Vision Inc
Study ID
NCT06625749
Status
Recruiting
Apply to this trial

Conditions

  • Refractive Error - Myopia
  • Refractive Surgery

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Accurasee™ IOPCL — DEVICE
    Intraocular pseudophakic capsular lens (IOPCL)

Study Details

This is a study to evaluate the safety and effectiveness of the AccuraSee™ intraocular pseudophakic capsular lens (IOPCL) to improve near and/or intermediate vision following previous cataract surgery.

Key Dates

Start date
Sep 23, 2024
Status verified
Oct 2024
Primary completion
Mar 31, 2026
Completion
Mar 31, 2026

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: AccuraSee™ intraocular pseudophakic capsular lens (IOPCL)

Primary Outcome Measure

Improvement in uncorrected near visual acuity (UCNVA) at 40 cm/16 inches [ Time Frame: 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Midwest Vision PartnersClevelandOhio44141
Julia Kantorik, COA
[email protected]
Erin Kus-Kreidler, COA, CCRC
[email protected]
William Wiley, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Cleveland, OH

By research site
Midwest Vision Partners· Cleveland, OH

Related Studies